Global Image-Guided Radiation Therapy Market 2023-2030

Global Image-Guided Radiation Therapy Market 2023-2030

Global Image-guided radiation therapy Market Size, Share & Trends Analysis Report by Product (4D RT, LINAC, MRI-guided radiotherapy, and Portal CT Imaging), by Procedure (IMRT, Stereotactic, and Particle), and by Application (Neck, Prostate, Breast, Cervical, Lung, and Other), Forecast Period (2023-2030)

The global image-guided radiation therapy market is anticipated to grow at a CAGR of 6.1% during the forecast period (2023-2030). Image guided radiotherapy is a type of conformal radiotherapy which involves the use of different scans and X-rays which can treat the infected area of cancer. Conformal radiotherapy shape the radiotherapy beams around the area of the cancerous tissue. In this therapy the use of X-rays and scans similar to CT scans before and during the radiotherapy treatment. It improves the precision and accuracy of treatment delivery. These therapies are majorly used in the treatment of cancer such as neck cancer, lung cancer, cervical cancer and others.

Segmental Outlook

The global image-guided radiation therapy market is segmented on the product, procedure, and application. Based on the product, the market is sub-segmented into 4D RT, LINAC, MRI-guided radiotherapy, and Portal CT Imaging. Based on the procedure, the market is sub-segmented into IMRT, Stereotactic, and Particle. Further, on the basis of application, the market is sub-segmented into Neck, Prostate, Breast, cervical, lung and others. Among the products, the MRI-guided radiotherapy sub-segment is anticipated to hold a considerable share of the market. Magnetic Resonance Imaging Guided Linear Accelerator (MRI-LINAC) uses magnetic resonance imaging, together with radiotherapy to treat cancers throughout the body, with specific advantages for soft-tissue tumors. The radiation delivery on the MRI-LINAC is fully integrated with the MRI. Which means the system can deliver treatment radiation beams and monitor the target area at the same time. The unique combination of technologies gives our physicians greater control over the delivery of radiation because they can see the internal anatomy and tumor.

The Cervical Sub-Segment is Anticipated to Hold a Considerable Share of the Global Image-guided Radiation Therapy Market

Among the application, the cervical cancer sub-segment is expected to hold a considerable share of the global programmatic advertisement market. The segmental growth is attributed to the growing prevalence of cervical cancer. Cervical cancer treatment has advanced dramatically over the last 20 years. Increased use of intensity-modulated radiation therapy (IMRT) and image-guided brachytherapy, in particular, have resulted in better patient outcomes and fewer treatment complications. According to an estimate of American society for radiation oncology, 13,800 American women will be diagnosed with invasive cervical cancer this year and nearly 4,300 women are expected to die from the disease. Cervical cancer can be highly treatable if detected early, however, the estimated five-year survival rate is 92 percent for early-stage disease and 56% for locally advanced disease. Cervical cancer can be highly treatable if detected early; the estimated five-year survival rate is 92 percent for early-stage disease.

Regional Outlook

The global image-guided radiation therapy market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-pacific is anticipated to hold a prominent share of the market across the globe, owing to the increasing number of generic population and increasing prevalence of cancer in the region.

The North America Region is Expected to Grow at a Significant CAGR in the Global Image-guided radiation therapy Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to increasing prevalence of cancer in the region. the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries and mortality data collected by the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States.

Hence, there is considerable shift of the country towards the adoption of the image-guided radiation therapy market solutions. Radiation is an integral part of cervical cancer treatment, either following surgery for patients at risk of recurrence or as a primary definitive treatment. The regimen involves pelvic external beam radiation therapy (EBRT), often combined with chemotherapy and a brachytherapy boost.

Market Players Outlook

The major companies serving the image-guided radiation therapy market include Siemens Ag, Hitachi Ltd, Koninklijke Philips, Elekta, Viewray Technologies Inc., C-Rad, Varian Medical Systems, Toshiba Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Chonnam National University Hwasun Hospital has recently introduced the latest radiation therapy system ‘Halcyon 3.0’ and utilized it for full-scale treatment. Halcyon 3.0 is a radiation cancer treatment device which is a cutting-edge equipment that can perform intensity-modulated radiation therapy based on real-time image guidance.

The introduced ‘Halcyon 3.0’ has the advantage of delivering precise and accurate treatment up to four times faster than standard technology.

The Report Covers

Market value data analysis of 2022 and forecast to 2030.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global image-guided radiation therapy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying ‘who-stands-where’ in the market.